Just a little "easter candy".....
I can't help but dig into other "biotech buyouts" and compare the devices and drugs that the company being bought out had at the time they were bought out, as well as look at who bought them and what price they were bought for.
The company that I researched today is called Medivation. They have a prostate cancer drug, Xtandi, which was their big one at the time of buyout as well as an Alzheimer's drug.
Xtandi PLUS GnRh therapy offers a 23% reduction in death over placebo PLUS GnRh therapy. The side effects and adverse reactions list is pretty immense. Everything from infection, fatigue and loss of appetite all the way to seizures, loss of consciousness and 1 patient in their clinical trial even died from sepsis related to the drug side effects.
***This company, Medivation, was sued in a class action lawsuit, by its Investors in November 2012, for inflating its share price by making false statements concerning the efficacy of its products.
Here's the biggest take away (WARNING!) from their drug that I found...
(On their own website!!)
"There have been post approval reports of Posterior Reversible Encephalopathy Syndrome (PRES), a neurological disorder that can present with rapidly evolving symptoms and requires confirmation by brain imaging. Discontinue Xtandi if patient develops PRES."
So even though their drug actually can cause a Neurological disorder as found AFTER drug approval, it can reduce death by 23% along with a ton of possible side effects, and its still considered an amazing drug!
So......
Pfizer came in and bought this company, outbidding 4 other companies, to add the prostate drug, Xtandi, to its arsenal.
They paid $16B in 2016 for the above company.
If you've done ANY DD at ALL on ENDV, then you know that our 21 patents, our devices and our technology DWARF the little prostate drug that this company had that sold for $16B.
Let's just say that we only got $16B for our world changing technology. Let's just say our 21 patents, our unprecedented technology and devices are only worth as much as a p.o.s. prostate drug that helps you 23% more than eating pills filled with air, but can cause severe side effects as well.
Let's just say that that's ALL that we are at best, is equal to them.
Then.....if you spent $1,050 tomorrow and bought in at our current price of .058, you'd end up with 18,103 shares of ENDV. If ENDV sold to a big company for the same price as that Medivation company that had 1 "sort of works" drug and that's about all,
then you'd still be a millionaire. ($1,013,793)
If you don't think that what we have here is exponentially more advanced and technologically superior to anything else out there, then you haven't done the DD that I have.
We have the ability to be SO big, that like some have said in here......there's no ceiling you can put on this.
I'm just incredibly thankful that it's hovering in the .05-.10 range for now so that I can accumulate more every week. I seriously think that for every $1 you invest, you will make $50+ MINIMUM....and that's lowballing it IMO.
